ARVO Foundation Announces Winner of
Oberdorfer Award in Low Vision Research
Awardee recognized for her genetic and clinical epidemiology research
Rockville, Md.—The Association for Research in Vision and Ophthalmology (ARVO) today announced the recipient of the Oberdorfer Award in Low Vision Research. The award, which honors Michael D. Oberdorfer, PhD, recognizes a recipient with a $1,250 honorarium, an inscribed award and invitations to several special events at the ARVO Annual Meeting. The 2021 recipient of the award is Caroline Klaver, MD, PhD of Erasmus Medical Center, Radboud University Medical Center, and the Institute of Molecular and Clinical Ophthalmology Basel (IOB).
First presented in 2012, the Oberdorfer Award in Low Vision Research is supported by the Lighthouse Guild through the ARVO Foundation and honors Dr. Oberdorfer, who served for many years at the National Eye Institute (NEI) as director of Strabismus, Amblyopia and Visual Processing and director of Low Vision and Blindness Rehabilitation for the NEI Extramural Research Program. His support of low vision research led to an expansion of funded grants in that field.
2021 recipient Klaver is an ophthalmologist and epidemiologist connected to Erasmus Medical Center Rotterdam, Radboud University Medical Center in Nijmegen, and Institute of Molecular and Clinical Ophthalmology Basel, University of Basel. Her research group focuses on genetic and clinical epidemiology of age-related macular degeneration (AMD), myopia, glaucoma, and as a retinal specialist she focuses on medical retina, retinal dystrophies and myopia. Klaver leads the eye section of the large population-based “Rotterdam Study” and “Generation R” and is a founder of the international consortia comprised of CREAM, EYE-RISK/E3 and IGGC. Her notable scientific contributions include identification of the first genes for age-related macular degeneration (APOE) and myopia (GJD2) and as well as gene-environment interaction between AMD genes and diet, and between myopia genes, education and lifestyle in childhood. She has been a pioneer in treatment of myopia progression in European children, and an advocate for the incorporation of preventative regimens into standard clinical care.
“It is a great honor to receive this award,” says Klaver. “The award will increase my visibility and it will give me the opportunity to strengthen existing collaborations and to enter into new collaborations.”
To learn more about the Oberdorfer Award in Low Vision Research, visit ARVO’s website
# # #
The Association for Research in Vision and Ophthalmology (ARVO) is the largest eye and vision research organization in the world. Members include approximately 10,000 eye and vision researchers from over 75 countries. ARVO advances research worldwide into understanding the visual system and preventing, treating and curing its disorders. Learn more at ARVO.org.
Established in 2001, the ARVO Foundation for Eye Research raises funds through partnerships, grants and sponsorships to support ARVO’s world-class education and career development resources for eye and vision researchers of all stages of career and education. Learn more at ARVOFoundation.org.